Temple Health Chest Initiative (THCI 2.0)

Recruiting now

Conditions studied: Chronic Obstructive Pulmonary Disease (COPD)

In brief

Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.

Key facts

Study ID

NCT06933758

Run by

Temple University

People needed

1000

Starts

2025-02-28

Expected to finish

2026-06-30

Last updated by the study team

2025-04-18

Who can join

Age: 50 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 50 to 80 years old
• Screened for early lung cancer using low dose CT imaging

You may not qualify if…

• Under 50; over 80 years old
• No lung cancer screening

Where it is running

• Temple University Of the Commonwealth System of Higher Education — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.